Liberty Dialysis

What Liberty Dialysis does

Liberty Dialysis is a dialysis services and home dialysis products business now operating as a brand/division within Fresenius Medical Care AG, the publicly listed German dialysis company headquartered in Bad Homburg. Originally founded in 2002 and headquartered in Mercer Island, Washington, Liberty Dialysis affiliates develop and operate dialysis clinics and run chronic kidney disease outreach and home dialysis programs, with reported headcount of 5,001–10,000 employees across its clinic and product operations. The Liberty brand centers on the Liberty Select Cycler, an automated peritoneal dialysis (PD) device indicated for acute and chronic PD, paired with the kinexus Remote Therapy Management platform. The cycler transmits post-treatment data to the dialysis center for remote monitoring and accepts adjusted therapy programs for remote programming, reducing reliance on paper flow sheets. Supporting technologies include stay•safe PIN technology for touch-contamination reduction, an upgradable operating system enabling existing installed cyclers to gain remote therapy programming (updates averaging under 30 minutes), PD Plus daytime exchange, and treatment-based and cycle-based therapy modes.

Liberty Dialysis monetizes through hardware sales of the Liberty Select Cycler and related disposables, distributed through Fresenius Medical Care's global network of dialysis centers, physician channels, and country-specific websites spanning 45+ countries. Under U.S. federal law, the device must be sold by or on the order of a physician, so GTM is enterprise/clinical field sales into dialysis centers and nephrology practices rather than direct-to-consumer. The customer base is bifurcated: dialysis centers and healthcare providers (primary business-unit segment purchasing equipment) and home PD patients (end-user persona treated through those providers). The product is positioned to grow home dialysis penetration by addressing ease-of-use, connected remote therapy management, and reduced patient attrition — the company cites an 89% reduction in PD patient attrition risk in the first year when five or more prescription alterations are made (though it disclaims this figure is not associated with remote patient monitoring). Pricing is not publicly disclosed. Historical capital history shows Bain Capital Ventures as a 2002 seed investor, followed by large 2010 rounds from InvestMichigan ($314.96M) and Norwest Mezzanine Partners ($35M), after which the company was integrated into Fresenius Medical Care's broader kidney-care portfolio.

Name

Liberty Dialysis

Legal name

Liberty Dialysis (Brand of Fresenius Medical Care)

Website

https://libertydialysis.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Liberty Dialysis operates dialysis clinics and home peritoneal dialysis programs under Fresenius Medical Care, offering the Liberty Select Cycler with the kinexus Remote Therapy Management platform to dialysis centers, physicians, and home PD patients globally.

Ownership category

akta.pro rank

Product category

Dialysis Services

NAICS

Kidney Dialysis Centers (621492)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Peritoneal Dialysis (PD) Systems & Supplies (HLAHAKAB)

akta.pro secondary industries

Home Dialysis Equipment & Remote Monitoring (HLAHAKAG), Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support) (HLALAFAC)

Keywords

• Dialysis clinic operations
• Home dialysis programs
• Kidney disease care
• Peritoneal dialysis equipment
• Chronic kidney disease

Headquarters

HQ city

Mercer Island

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of Liberty Select Cycler and related peritoneal dialysis equipment to dialysis centers, healthcare providers, and patients. Hardware sales model with medical devices sold through healthcare provider channels.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Liberty Dialysis affiliates, develops and operates dialysis clinics and offers chronic kidney disease outreach and home dialysis programs. Under the Fresenius Medical Care umbrella, the Liberty brand delivers the Liberty Select Cycler, an automated peritoneal dialysis (PD) device integrated with the kinexus Remote Therapy Management platform, enabling home-based renal replacement therapy with remote monitoring and programming by healthcare providers.

Product overview

Liberty Dialysis (Fresenius Medical Care) offers a portfolio of home dialysis products centered on the Liberty Select Cycler, an automated peritoneal dialysis (PD) system. The Liberty Select Cycler integrates with the kinexus Remote Therapy Management platform, enabling healthcare providers to customize treatment options, monitor patients remotely, and program therapies from the dialysis center. The product portfolio includes the Liberty Select Cycler with kinexus for automated PD, the stay•safe CAPD System for continuous ambulatory peritoneal dialysis, and the kinexus Therapy Management Platform for remote therapy management. These offerings are designed to address patient clinical and lifestyle needs while supporting staff efficiency and home dialysis growth.

Differentiator

Problem solved

Functional benefit

Brands

• Liberty Select Cycler: Peritoneal dialysis cycler for home use, featuring kinexus Remote Therapy Management platform for connected PD therapy.
• Liberty

Products and services

• Liberty Select Cycler

Quantifiable outcome

• 89% reduced risk of PD patient attrition in the first year when 5 or more prescription alterations are made

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Scale indicators2 records

Expansion highlights4 records

Emerging players

• Outset Medical: Outset's Tablo Hemodialysis System is approved for in-center, home, and acute care, increasingly competing for the home-dialysis patient that Liberty targets; it represents the new wave of connected, simplified dialysis consoles.

Regional players

• Satellite Healthcare: Satellite Healthcare is a U.S.-focused, nonprofit dialysis provider with a strong home-dialysis program; a meaningful channel and outcome-data partner comparable to the dialysis-center customers Liberty serves.
• U.S. Renal Care: U.S. Renal Care is the third-largest U.S. dialysis services provider and a sizable purchaser of PD equipment and supplies; relevant because its home-dialysis growth decisions directly shape demand for Liberty cyclers.
• Diaverum: Diaverum operates a large international network of dialysis clinics across Europe, LATAM, the Middle East, and Africa; comparable as a buyer and channel partner for Liberty-class home PD equipment in non-U.S. markets.
• American Renal Associates (Innovative Renal Care): Innovative Renal Care operates dialysis centers across the U.S. and is a relevant customer-side peer for home-dialysis device adoption decisions affecting Liberty cycler placements.

Broad incumbents

• DaVita: DaVita is one of the two largest U.S. dialysis providers and a major buyer of home dialysis equipment; it is a key customer and channel influence for Liberty-class cyclers, and increasingly runs its own home programs that compete with FMC/Liberty-driven offerings.
• Fresenius Medical Care AG: Liberty's own parent and the world's largest dialysis services and product company — the relevant benchmark for Liberty because the same FMC network sells in-center HD machines, runs dialysis clinics, and competes with Baxter across every modality.

Direct peers

• Baxter International: Baxter is the global leader in peritoneal dialysis with the HomeChoice Claria and Amia automated PD cyclers plus Sharesource remote patient monitoring — the most direct head-to-head competitor to the Liberty Select Cycler and kinexus platform.
• B. Braun Avitum: B. Braun sells the Dialog+ hemodialysis system and offers PD products; competes with Liberty in renal care devices globally and shares the OEM-quality, integrated-platform positioning.

Others

• Cleveland Clinic / Mayo Clinic nephrology programs: Leading U.S. nephrology centers that prescribe and shape adoption of home-PD technology like Liberty; relevant as prescriber/influencer peers rather than direct product competitors.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat5 records

Key risks4 records

Key highlights5 records

Customer concentration

• Xx.com/FME_Global
• YouTubeyoutube.com/c/FreseniusMedicalCareNorthAmerica
• Facebookfacebook.com/FreseniusMedicalCareNA
• LinkedInlinkedin.com/company/liberty-dialysis-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Liberty Dialysis